Association of Kidney Damage Markers with Bleeding Risk in CKD and Atrial Fibrillation During Rivaroxaban Treatment
Ranokhon IgamberdievaTashkent Pediatric Medical Institute, Tashkent, Tashkent Province, Uzbekistan;Sherzod AbdullaevRepublican Specialized Scientific and Practical Medical Center for Nephrology and Kidney Transplantation, Tashkent, Tashkent Province, Uzbekistan
ABI
Аннотация
Аннотация отсутствует.
Темы
Идентификаторы
Цитирования и источники
Цитирований: 0Использованных источников: 0
Показатели — AkademScholar · Скоро